NSE: JHS · PERSONAL CARE

JHS Svendgaard Laboratories Limited Share Price & Company Info

₹8.11+0.75%

End-of-day price, · Educational content, not investment advice

52W low ₹6.2652W high ₹13.69
Market cap
₹69.84 Cras reported by NSE
52-week high
₹13.6901-OCT-2026
52-week low
₹6.2630-MAR-2026
Face value
₹10.00
Shares issued
8,74,05,767
Volume
15,730₹0.01 Cr traded
Price band
5%₹7.79 – ₹8.59 on 2026-11-02
Annual volatility
72.60%NSE, from daily returns
Series
BEtrade-for-trade
BSE group
Tscrip code 532771
ISIN
INE544H01014
Listed on NSE
21-Oct-2006

About JHS Svendgaard Laboratories Limited

JHS Svendgaard Laboratories Limited is listed on the National Stock Exchange of India under the symbol JHS in the BE series. NSE classifies it under the basic industry Personal Care, part of the Fast Moving Consumer Goods sector. Its shares were listed on NSE on 21-Oct-2006. Each share has a face value of ₹10.00.

In the end-of-day data for 16 November 2026 the stock closed at ₹8.11, up 0.75% on the day. NSE puts the company's market capitalisation at about ₹69.84 crore, which puts it among the smallest listed companies in India. Over the past 52 weeks it has traded between ₹6.26 and ₹13.69, so the last price is 29.6% above the low and 40.8% below the high.

BE is a trade-for-trade series: every buy must be taken as delivery and every sell must be delivered, so intraday trading is not allowed. Exchanges move stocks here for surveillance reasons, often because of unusual price or volume behaviour.

NSE currently lists a regulatory note for this stock: ESM-1 | EPS based on prev. 4 trailing Qtrs. in the scrip is zero, NSE's Enhanced Surveillance Measure for micro and small companies; at stage I every trade is settled by delivery (trade-for-trade) and a 100% margin applies. Notes like these come from the exchange's surveillance and disclosure checks and can mean higher margins, trade-for-trade settlement or limits on trading. Check the NSE quote page for the current position before trading.

NSE puts the stock's annualised volatility at 72.60%. That is very high: moves of several percent in a single day are routine.

Because the share trades below ₹10, it also appears in our list of penny stocks under ₹10, which explains the extra risks that come with low-priced shares.

JHS Svendgaard Laboratories Limited quarterly results

In the quarter ended June 2026 (un-audited), JHS Svendgaard Laboratories Limited reported total income of ₹30.47 crore and a net profit of ₹1.09 crore, or ₹0.13 per share. That is a net margin of 3.6% on income.

Compared with the previous quarter (March 2026), income fell 8.8%.

JHS Svendgaard Laboratories Limited was profitable in 2 of the 4 quarters shown below. Figures are as filed with NSE, in ₹ crore.

Quarterly results filed with NSE (₹ crore, EPS in ₹)
Quarter endedTotal incomeProfit before taxNet profitEPSStatus
June 202630.470.061.090.13Un-Audited
March 202633.42-2.98-3.57-0.42Audited
December 202523.850.080.790.09Un-Audited
September 202523.42-0.01-0.20-0.02Un-Audited

JHS Svendgaard Laboratories Limited shareholding pattern

At the end of September 2026, promoters and the promoter group held 33.85% of JHS Svendgaard Laboratories Limited, with the public holding 66.15%. That is down 0.71 percentage points from 34.56% in March 2025.

Shareholding by category, as filed with NSE each quarter
Quarter endedPromoter & Promoter Group (%)Public (%)
September 202633.8566.15
June 202633.8566.15
March 202633.8566.15
February 202633.8566.15
December 202534.5665.44
September 202534.5665.44
June 202534.5665.44
March 202534.5665.44

JHS Svendgaard Laboratories Limited share price performance

Over the past year the JHS Svendgaard Laboratories Limited share price has lost 39.53%, against a fall of 10.92% for the NIFTY 50, so it has underperformed that index by 28.61 percentage points.

Across the 7 periods in the table, the stock beat the NIFTY 50 in 1. Past returns describe what happened; they do not predict what comes next.

Price change by period, as of 2026-11-02 (NSE)
PeriodJHSNIFTY 50
1 month-35.74%+1.91%
3 months+9.89%-5.20%
6 months-9.60%-3.94%
1 year-39.53%-10.92%
2 years-68.32%-5.29%
3 years-62.96%+20.44%
5 years-67.35%+30.45%

JHS Svendgaard Laboratories Limited vs industry peers

NSE compares JHS Svendgaard Laboratories Limited with 6 other listed companies in Personal Care. By market capitalisation it ranks 5 of 7.

NSE industry peer comparison, results for JUN 2026 quarter (₹ crore)
CompanyMarket capPrice (₹)P/EPromoter %Qtr incomeQtr net profit
BAJAJCON4,830369.8019.2742.9734370.16
ANONDITA1,847970.0054.160.00——
MACOBSTECH192195.90—0.00——
AAKAAR10171.00—0.00——
JHS69.928.00—33.8530.471.09
MEDISTEP27.7119.504.630.00——
ANOND-RE15.09157.50—0.00——

JHS Svendgaard Laboratories Limited announcements, board meetings and corporate actions

Latest announcements

The most recent filings JHS Svendgaard Laboratories Limited has made with NSE, newest first:

  • 09-Oct-2026 · Certificate under SEBI (Depositories and Participants) Regulations, 2018: JHS Svendgaard Laboratories Limited has informed the Exchange about Certificate under Regulation 74(5) SEBI (Depositories and Participants) Regulations, 2018 (PDF)
  • 29-Sep-2026 · Shareholders meeting: JHS Svendgaard Laboratories Limited has submitted the Exchange a copy Srutinizers report and voting results of Annual General Meeting held on September 26, 2026. (PDF)
  • 26-Sep-2026 · Shareholders meeting: JHS Svendgaard Laboratories Limited has informed the Exchange about the Proceedings of 22nd Annual General Meeting of the Company. (PDF)
  • 21-Sep-2026 · Trading Window: JHS Svendgaard Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 (PDF)
  • 17-Sep-2026 · General Updates: JHS Svendgaard Laboratories Limited has informed the Exchange about letter sent to shareholders whose e-mail id not registerd (PDF)
  • 03-Sep-2026 · Copy of Newspaper Publication: JHS Svendgaard Laboratories Limited has informed the Exchange about Copy of Newspaper Publication regarding 22nd AGM Notice. (PDF)
  • 02-Sep-2026 · Shareholders meeting: JHS Svendgaard Laboratories Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 26, 2026 (PDF)
  • 29-Aug-2026 · Copy of Newspaper Publication: JHS Svendgaard Laboratories Limited has informed the Exchange about Copy of Newspaper Publication of advertisement regarding the details of Annual General Meeting. (PDF)

Board meetings

  • 02-Nov-2026 · Financial Results: To consider and approve the financial results for the period ended September 30, 2026
  • 11-Aug-2026 · Financial Results: To consider and approve the Un-Audited financial results (Standalone and Consolidated) for the period ended Jun 30, 2026
  • 26-May-2026 · Financial Results/Other business matters: To consider and approve the financial results for the period ended March 31, 2026 and other business matters
  • 10-Feb-2026 · Financial Results: To consider and approve the un-audited financial results for the period ended December 31, 2025
  • 14-Nov-2025 · Financial Results: The Company has informed the Exchange that a Board meeting to be held on November 13, 2025 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on November 14, 2025, To consider and approve the financial results for the period ended September 30, 2025

Corporate actions

None of the corporate actions on record is a dividend, split or bonus issue; they are meetings and book closures. The ex-date is the first day the shares trade without the entitlement.

  • Demerger · ex-date 11-Sep-2023 · record date 11-Sep-2023
  • Annual General Meeting · ex-date 06-Sep-2019 · book closure 11-Sep-2019 to 17-Sep-2019
  • Annual General Meeting · ex-date 03-Sep-2018 · book closure 05-Sep-2018 to 11-Sep-2018
  • Annual General Meeting · ex-date 21-Aug-2017 · book closure 23-Aug-2017 to 29-Aug-2017
  • Extra Ordinary General Meeting · ex-date 02-Jan-2017 · book closure 04-Jan-2017 to 10-Jan-2017
  • Annual General Meeting · ex-date 11-Aug-2016 · book closure 16-Aug-2016 to 22-Aug-2016
  • Annual General Meeting · ex-date 21-Aug-2015 · book closure 25-Aug-2015 to 01-Sep-2015
  • Annual General Meeting · ex-date 18-Dec-2014 · book closure 20-Dec-2014 to 27-Dec-2014
  • Annual General Meeting · ex-date 13-Sep-2013 · book closure 17-Sep-2013 to 23-Sep-2013
  • Annual General Meeting · ex-date 30-Aug-2012 · book closure 02-Sep-2012 to 05-Sep-2012

Risk notice: low-priced and small-company shares can be illiquid, volatile and subject to manipulation, and shareholders can lose their entire investment. This page is a factual summary, not a recommendation to buy or sell JHS Svendgaard Laboratories Limited.

Where to find JHS Svendgaard Laboratories Limited's financials

Direct downloads from NSE:

For full financial statements, shareholding detail and every company announcement, go to the source:

Other Personal Care stocks on MCX Trends

Frequently asked questions

What is the JHS Svendgaard Laboratories Limited share price?

JHS Svendgaard Laboratories Limited (NSE: JHS) closed at ₹8.11 in the end-of-day data for 16 November 2026. For a live price, use the NSE quote page or your broker, because this page is updated from end-of-day files.

Which sector does JHS Svendgaard Laboratories Limited belong to?

NSE classifies JHS Svendgaard Laboratories Limited under Personal Care, in the Fast Moving Consumer Goods sector.

What is the 52-week high and low of JHS?

The 52-week high is ₹13.69 (01-OCT-2026) and the 52-week low is ₹6.26 (30-MAR-2026), according to NSE.

Is JHS Svendgaard Laboratories Limited a penny stock?

At ₹8.11 the share trades below ₹10, so it appears on our list of penny stocks under ₹10. A low share price on its own says nothing about whether a company is cheap or expensive; market capitalisation, debt, profits and exchange surveillance status matter far more.

What is the promoter holding in JHS Svendgaard Laboratories Limited?

Promoters and the promoter group held 33.85% of JHS Svendgaard Laboratories Limited at the end of September 2026, according to the shareholding pattern filed with NSE.

What were JHS Svendgaard Laboratories Limited's latest quarterly results?

For the quarter ended June 2026, JHS Svendgaard Laboratories Limited reported total income of ₹30.47 crore and a net profit of ₹1.09 crore (EPS ₹0.13).

Where can I find JHS Svendgaard Laboratories Limited's annual report and financial results?

Annual reports, quarterly results and other filings are published on the NSE corporate filings pages (search for JHS) and on BSE. Screener also lays out several years of financial statements in one place. Links to all of these are above.

More on MCX Trends